ABBV vs CB · P/E 81, rev $61.16B vs P/E 14, rev $59.40B
AbbVie Inc (ABBV) versus Chubb Ltd (CB) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Not investment advice. Open the ABBV and CB stock pages for the full models.
Not investment advice.